KeyIntel Medical Inc
KeyIntel Medical Inc
KeyIn-1 is a novel blood biomarker test to assess inflammation and repair in chronic inflammatory diseases.
Initial applications:
✅ Axial spondyloarthritis
✅ Chronic Low Back Pain
✅ Inflammatory Bowel Disease
Inflammatory Disease Biomarkers: Limitations
🔴 Current therapies mask inflammatory pain while inflammation can continue to progress. Persisting inflammation, even if asymptomatic, leads to increasing disability
🔴 Current Biomarkers fail to assess the presence and intensity of chronic inflammation adequately, and do not assess presence or activity of tissue repair
❗Improved inflammation biomarkers are needed for axial spondyloarthritis to assist with early diagnosis, to better predict treatment and outcomes
Mathew Brown, Nature Reviews, Rheumatology 2020 16 449
KeyIn-1 resolves unmet clinical needs for chronic inflammatory disease assessment and therapy.
What does KeyIn-1 do?
KeyIn-1 utilizes well known inflammation biomarkers, LCN2 and LCN2-MMP9, and leverages Artificial Intelligence, to analyze the presence, intensity, and balance of inflammation and repair.
KeyIn-1 provides a quantitative comprehensive assessment of the patient's chronic inflammation condition.
What makes KeyIn-1 different?
The applications of KeyIn-1 extend beyond a single disease diagnosis. KeyIn-1 can assist in differential diagnosis of early disease, quantitate inflammation/repair activity, disease activity in every patient. KeyIn-1, detects the inflammation/repair balance, and can help evaluate treatment efficacy, features all of which were previously not accessible by laboratory diagnosis.
How can KeyIn-1 impact patient care?
Wide adoption of the KeyIn-1 for Axial Spondyloarthritis and Chronic Low Back Pain populations initially, followed by adoption for other chronic inflammatory diseases, will reduce delays to diagnosis and will provide better assessment of each patient's disease activity.
KeyIn-1, once fully deployed, could save at least 10% on current treatment costs for chronic inflammatory diseases.
KeyIntel Team Members
Our team includes serial entrepreneurs in laboratory diagnostics with deep expertise in rheumatology, pathology, biomarker science, and artificial intelligence applications.
Management
Ken Pritzker MD,FRCPC
CEO
Serial Entrepreneur,
Laboratory Diagnostics
John Jordan MBA,CPA,CMA
CFO
Serial Entrepreneur,
Laboratory Diagnostics
Arash Samari MSc.
Principal Scientist
Artificial Intelligence Expert
Advisors
Florence Tsui PhD
Senior Science Advisor
Spondylitis research, Biomarker discovery
Robert Inman MD,FRCPC
Senior Clinical Advisor
Clinical leader,
Spondylitis research,
Biomarker discovery
Contact us
Ken Pritzker, CEO
Email: kpritzker@keyintelmedical.com
John Jordan, CFO
Email: jjordan@keyintelmedical.com
Address: MaRS Centre, 101 College Street, Suite 200, Toronto, ON, M5G 1L7, CANADA